Rare clinical presentations and advances in the treatment of Buerger's disease - narrative review
DOI:
https://doi.org/10.12775/QS.2024.24.53931Keywords
Buerger’s disease, thromboangiitis obliterans, thrombosis, atherosclerosis, peripheral arterial disease, vasculitisAbstract
Introduction
Buerger's disease (BD) is an inflammatory disease with an etiology that is still not fully understood. It involves venous and arterial vessels, of small and medium caliber, of the lower and upper extremities (Cacione et al., 2020). This inflammation predominantly affects young, tobacco-smoking men, usually those before the age of 40. Literature data relating to peripheral arterial disease in general, put the prevalence of BD at between 0.5%-5.6% in Western European countries (Liu et al., 2023; Öztan et al., 2023). In this paper, we summarized the latest literature reports on rare clinical images and new directions in the treatment of Buerger's disease.
Aim of the study
The purpose of this systematic review was to compile the latest literature on the etiology, atypical disease presentation, associations with other diseases and modern treatment of Buerger's disease.
Materials and methods
The materials used by our team were obtained from a review of the currently available literature in the PubMed database. To search for articles, we used keywords such as: Buerger’s disease, thromboangiitis obliterans, thrombosis, atherosclerosis, Peripheral arterial disease, vasculitis.
Conclusion
In addition to its characteristic clinical presentation, Buerger's disease can present under a number of atypical forms. Such examples, less common conditions in the course of BD are intestinal vascular involvement mimicking the condition of acute abdomen, infertility condition due to gonadal involvement in the patient, possible correlation between the level of ASA (anti-sperm antibodies) and reduced fertility, the occurrence of nail lesions, renal complications, including the nephrotic syndrome, ocular or psychiatric manifestations. It is important for the clinician, in the diagnostic and therapeutic process at the onset of the described symptoms, not to exclude the possibility of an uncommon course of BD, to make a correct diagnosis and undertake optimal treatment.
References
Awara, M. A., Downing, L. M., & Elnenaei, M. O. (2023). Psychiatric sequelae of thromboangiitis obliterans: A case report and review of the literature. Journal of Medical Case Reports, 17(1), 40. https://doi.org/10.1186/s13256-022-03694-z
Cacione, D. G., Macedo, C. R., do Carmo Novaes, F., & Baptista-Silva, J. C. (2020). Pharmacological treatment for Buerger’s disease. Cochrane Database of Systematic Reviews, 2020(5), CD011033. https://doi.org/10.1002/14651858.CD011033.pub4
Choi, B., Jang, S. Y., Kim, S. K., Kim, N., Kim, K., & Kim, D. K. (2020). The incidence, prevalence, and survival rate of thromboangiitis obliterans in Korea: A retrospective population-based study. Cardiovascular Diagnosis and Therapy, 10(5), 1238-1244. https://doi.org/10.21037/cdt-20-582
Chung, M. H., Lee, J. S., & Kang, J. S. (2022). Buerger’s disease may be a chronic rickettsial infection with superimposed thrombosis: Literature review and efficacy of doxycycline in three patients. Infection & Chemotherapy, 54(1), 20-58. https://doi.org/10.3947/ic.2021.0146
Ejiyooye, T. F., Ajibowo, A. O., Dirisanala, S., Olagbende, B., Ezenagu, U. E., & Khan, A. (2022). A rare case of thromboangiitis obliterans of bilateral upper extremities in an adult male. Cureus, 14(5), e24975. https://doi.org/10.7759/cureus.24975
Fujioka, A., Yanishi, K., Yukawa, A., Imai, K., Yokota, I., Fujikawa, K., Yamada, A., Naito, A., Shoji, K., Kawamata, H., Higashi, Y., Ishigami, T., Sasaki, K. I., Tara, S., Kuwahara, K., Teramukai, S., & Matoba, S. (2023). A multicenter prospective interventional trial of therapeutic angiogenesis using bone marrow-derived mononuclear cell implantation for patients with critical limb-threatening ischemia caused by thromboangiitis obliterans. Circulation Journal, 87(9), 1229-1237. https://doi.org/10.1253/circj.CJ-23-0046
Gupta, P. K., Dutta, S., Kala, S., Nekkanti, M., Desai, S. C., Mahapatra, S. S., Dhar, A., Raju, R., M R, Behera, A., P S, Raviraja, N. S., Viswanathan, P., Chandrashekar, M., Thej, C., K V P, Abraham, J., Boggarapu, H., & Udaykumar, K. (2021). Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger’s disease. Stem Cells Translational Medicine, 10(12), 1602-1613. https://doi.org/10.1002/sctm.21-0197
Harwood, E. A., Blazek, A. J., Radio, S. J., & Deibert, C. M. (2023). Buerger’s disease in the testicle: A case of testicular thromboangiitis obliterans. Cureus, 15(4), e37693. https://doi.org/10.7759/cureus.37693
Iwai, T., Kume, H., Koizumi, S., Sakurazawa, K., Honma, K., Ogasawara, H., Takemura, T., Kishino, M., & Kagayama, T. (2022). Buerger disease: Pathological changes in elderly patients. Annals of Vascular Diseases, 15(1), 29-36. https://doi.org/10.3400/avd.oa.21-00142
Jaroonwanichkul, S., & Hall, J. C. (2023). Decreasing tobacco use promotes ulcer healing in a patient with Buerger’s disease. Clinical Case Reports, 11(2), e6999. https://doi.org/10.1002/ccr3.6999
Kim, J. H., Kim, H., Koh, I. C., & Lim, S. Y. (2023). Buerger’s disease as a cause of post-operative skin necrosis: A case report. Journal of Personalized Medicine, 13(1), 108. https://doi.org/10.3390/jpm13010108
Komiya, D., Iwai, K., & Ohno, T. (2023). Efficacy of supervised exercise therapy for intermittent claudication in a case with Buerger’s disease. Cureus, 15(8), e43279. https://doi.org/10.7759/cureus.43279
Liu, Z., Zhou, C., Guo, H., Wang, M., Liang, J., & Zhang, Y. (2023). Knowledge mapping of global status and trends for thromboangiitis obliterans: A bibliometrics and visual analysis. Journal of Pain Research, 16, 4071-4087. https://doi.org/10.2147/JPR.S437521
Mishra, S. S., Mishra, T. S., Mitra, S., & Kumar, P. (2021). Intestinal thromboangiitis obliterans: A case report. Journal of Medical Case Reports, 15(1), 215. https://doi.org/10.1186/s13256-021-02719-3
Öztan, G., Bozbuğa, N., İşsever, H., Oğuz, F., Canıaz, İ., Yazıksız, N., Ertan, M., & Alpagut, İ. U. (2023). Comparative analysis of transcriptome profiles in patients with thromboangiitis obliterans. Genes, 15(1), 19. https://doi.org/10.3390/genes15010019
Qaja, E., Muco, E., & Hashmi, M. F. (2023). Buerger disease. In StatPearls. Treasure Island, FL: StatPearls Publishing. https://doi.org/10.5201/ip-acs23
Salimi, J., Cheraghali, R., Omrani, Z., Farshidmehr, P., & Afghani, R. (2022). Surgical treatment options for Buerger’s disease (Experience with 315 cases in Iran). Medical Journal of the Islamic Republic of Iran, 36, 134. https://doi.org/10.47176/mjiri.36.134
Shapouri-Moghaddam, A., Saeed Modaghegh, M. H., Rahimi, H. R., Ehteshamfar, S. M., & Tavakol Afshari, J. (2019). Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review. Iranian Journal of Basic Medical Sciences, 22(3), 215-224. https://doi.org/10.22038/ijbms.2019.31119.7513
Shapouri-Moghaddam, A., Tavakkol Afshari, S. J., Rahimi, H. R., Saeed Modaghegh, M. H., & Mahmoudi, M., & Ehteshamfar, S. M. (2021). Para-clinical and immunological evaluation in Buerger’s disease as a suspected autoimmune disease: Case series. Reports of Biochemistry and Molecular Biology, 9(4), 379-384. https://doi.org/10.52547/rbmb.9.4.373
Sharebiani, H., Fazeli, B., Maniscalco, R., Ligi, D., & Mannello, F. (2020). The imbalance among oxidative biomarkers and antioxidant defense systems in thromboangiitis obliterans (Winiwarter-Buerger disease). Journal of Clinical Medicine, 9(4), 1036. https://doi.org/10.3390/jcm9041036
Starace, M. V. R., Alessandrini, A., Tosti, A., & Piraccini, B. M. (2022). Nails involvement in Winiwarter-Buerger disease. Skin Appendage Disorders, 8(2), 142-145. https://doi.org/10.1159/000518982
Szydełko-Paśko, U., Przeździecka-Dołyk, J., Małecki, R., Szuba, A., & Misiuk-Hojło, M. (2022). Ocular manifestations of Buerger’s disease - A review of current knowledge. Clinical Ophthalmology, 16, 851-860. https://doi.org/10.2147/OPTH.S352608
Watanabe, Y., Shimizu, Y., Hashimoto, T., Iwahashi, T., Shigematsu, K., Nakaoka, Y., Harigai, M., & Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS). (2024). Demographic traits, clinical status, and comorbidities of patients with thromboangiitis obliterans in Japan. Circulation Journal, 88(3), 319-328. https://doi.org/10.1253/circj.CJ-23-0211
Yamaguchi, N., Fukuda, A., Furutera, N., Kimoto, M., Maruo, M., Kudo, A., Aoki, K., Nakata, T., Uesugi, N., & Fukunaga, N., & Shibata, H. (2022). Nephrotic syndrome associated with Buerger’s disease. Internal Medicine, 61(6), 865-869. https://doi.org/10.2169/internalmedicine.7885-21
Yanishi, K., Shoji, K., Fujioka, A., Hori, Y., Yukawa, A., & Matoba, S. (2020). Impact of therapeutic angiogenesis using autologous bone marrow-derived mononuclear cell implantation in patients with no-option critical limb ischemia. Annals of Vascular Diseases, 13(1), 13-22. https://doi.org/10.3400/avd.ra.20-00002
Ziaeemehr, A., Sharebiani, H., Taheri, H., & Fazeli, B. (2022). Secondary infertility: A neglected aspect of Buerger’s disease. Reports of Biochemistry and Molecular Biology, 11(2), 246-251. https://doi.org/10.52547/rbmb.11.2.246
Zou, J., Xu, W., Li, Z., Gao, P., Zhang, F., Cui, Y., & Hu, J. (2023). Network pharmacology-based approach to research the effect and mechanism of Si-Miao-Yong-An decoction against thromboangiitis obliterans. Annals of Medicine, 55(1), 2218105. https://doi.org/10.1080/07853890.2023.2218105
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Damian Chruścicki, Paulina Bednarczyk, Wojciech Kulej, Wojciech Płonka, Marcin Pelc, Gracjan Sitarek, Marta Żerek, Jakub Waszczyński
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 73
Number of citations: 0